| Identification | Back Directory | [Name]
1,2,4-Oxadiazol-5(2H)-one, 3-[1-[2-[[3-[2,3-dihydro-3-[4-[(methylsulfonyl)methyl]phenyl]-2-oxo-1H-imidazol-1-yl]-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl]-2-methylcyclopropyl]- | [CAS]
2763621-11-8 | [Synonyms]
GLP-1R agonist 15 1,2,4-Oxadiazol-5(2H)-one, 3-[1-[2-[[3-[2,3-dihydro-3-[4-[(methylsulfonyl)methyl]phenyl]-2-oxo-1H-imidazol-1-yl]-2-(4-fluoro-3,5-dimethylphenyl)-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-(tetrahydro-2H-pyran-4-yl)-1H-indol-1-yl]-2-methylcyclopropyl]- | [Molecular Formula]
C46H47FN8O7S | [MOL File]
2763621-11-8.mol | [Molecular Weight]
874.98 |
| Hazard Information | Back Directory | [Uses]
GLP-1R agonist 15 (Compound 101) is a GLP-1 receptor agonist[1]. | [References]
[1] Qinghua Meng, et al. Heterocyclic glp-1 agonists. WO2022048665A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|